# 

#    SCIENCE 

# DEEP DIVES

# 

# 

# 

# 

# 

# 

# 

# 

# 

# Science Deep Dives

# 

[\#1 Symptoms as Competence](##1-symptoms-as-competence)	3

[\#2 Placebo as Medicine (Science DeepDive)](##2-placebo-as-medicine-\(science-deepdive\))	5

[\#3 What Xanax Is \- and What It Actually Does](##3-what-xanax-is-–-and-what-it-actually-does)	8

[\#4 Why “Scrambling” Works](##4-why-“scrambling”-works)	11

# 

# \#1 Symptoms as Competence {##1-symptoms-as-competence}

# Why Symptoms Make Sense: A Resource- and Competence-Oriented View on Panic and Anxiety

Symptoms such as panic attacks, chronic anxiety, or compulsive behaviors are commonly treated as malfunctions of the mind or nervous system. Contemporary psychological and neuroscientific research, however, supports a fundamentally different interpretation: symptoms are adaptive regulatory responses, learned and maintained because they successfully fulfill specific functions.

From a systems perspective, the nervous system is not designed for happiness or coherence, but for survival, predictability, and regulation. Any pattern that reliably serves these goals tends to persist.

## **1\. Symptoms as Adaptive Solutions**

Repeated emotional and physiological patterns do not emerge randomly. Learning theory and affective neuroscience show that behaviors and internal states are stabilized when they reduce perceived threat or restore equilibrium—even if the long-term cost is high.

A panic attack, for example, provides:

* rapid mobilization of energy (fight-or-flight),  
* extreme attentional narrowing,  
* heightened bodily monitoring,  
* a strong sense of certainty (“something is happening, I know what this is”).

In the short term, this state can reduce ambiguity and helplessness, which are among the strongest triggers of stress responses. From a learning perspective, panic is negatively reinforced: it ends uncertainty by replacing it with a familiar, highly predictable internal state.

## **2\. Neurobiological Stabilization of Symptoms**

Neuroimaging and neurophysiological studies demonstrate that anxiety and panic are associated with recurrent activation patterns involving the amygdala, insula, brainstem nuclei, and prefrontal regions responsible for threat appraisal and interoception.

Crucially, the brain does not distinguish between external danger and internally generated threat signals. What matters is meaning, not objective reality. When a pattern reliably restores a sense of control, neural circuits supporting that pattern are strengthened through experience-dependent plasticity.

Thus, symptoms persist not because the system is broken, but because it is doing exactly what it has learned to do well.

## **3\. Secondary Gain and Emotional Regulation**

Clinical research consistently shows that symptoms often provide so-called secondary gains—not consciously intended benefits such as:

* predictability and control,  
* protection from overwhelming demands,  
* relational proximity or care,  
* stabilization of identity (“this explains me”).

Emotion-regulation research demonstrates that individuals will continue to use maladaptive strategies as long as they are effective in the short term, even when they impair functioning over time. This explains why insight alone rarely leads to lasting change.

## **4\. Why Pathologizing Fails**

Approaches that frame symptoms as defects or enemies tend to increase internal threat perception and defensive rigidity. In contrast, competence-oriented models align with empirical findings showing that change becomes possible only when the underlying regulatory function is acknowledged and replaced, not suppressed.

* Lasting transformation requires:  
* identifying the function the symptom fulfills,  
* recognizing the competence embedded in that function,  
* developing alternative strategies that meet the same regulatory needs with lower cost.

The goal is not symptom elimination, but functional reassignment, which is exactly the appoach Tony takes.

## **5\. Implications for Change**

From a scientific standpoint, symptoms disappear when they become unnecessary, not when they are fought. When the nervous system learns new, equally reliable ways to create safety, predictability, and regulation, old patterns lose their adaptive value.

In this sense, symptoms are not signs of weakness, but evidence of a system that learned to survive under constraint—and has not yet been offered a better option.

## **References**

1. Gross, J. J. (2015). Emotion regulation: Current status and future prospects. Psychological Inquiry, 26(1), 1–26. [https://doi.org/10.1080/1047840X.2014.940781](https://doi.org/10.1080/1047840X.2014.940781)   
2. Phelps, E. A., & LeDoux, J. E. (2005). Contributions of the amygdala to emotion processing: From animal models to human behavior. Neuron, 48(2), 175–187. [https://doi.org/10.1016/j.neuron.2005.09.025](https://doi.org/10.1016/j.neuron.2005.09.025)   
3. Bouton, M. E. (2007). Learning and behavior: A contemporary synthesis. Annual Review of Psychology, 58, 219–245. [https://doi.org/10.1146/annurev.psych.58.110405.085542](https://doi.org/10.1146/annurev.psych.58.110405.085542)   
4. Paulus, M. P., & Stein, M. B. (2010). Interoception in anxiety and depression. Brain Structure and Function, 214(5–6), 451–463. [https://doi.org/10.1007/s00429-010-0258-9](https://doi.org/10.1007/s00429-010-0258-9)   
5. Carver, C. S., & Scheier, M. F. (1990). Origins and functions of positive and negative affect: A control-process view. Psychological Review, 97(1), 19–35. [https://doi.org/10.1037/0033-295X.97.1.19](https://doi.org/10.1037/0033-295X.97.1.19)   
6. McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation. Physiological Reviews, 87(3), 873–904. [https://doi.org/10.1152/physrev.00041.2006](https://doi.org/10.1152/physrev.00041.2006) 

# \#2 Placebo as Medicine (Science DeepDive) {##2-placebo-as-medicine-(science-deepdive)}

# Why Placebos Work: The Placebo Effect as an Adaptive Regulatory Mechanism

The placebo effect is often misunderstood as deception, suggestion, or “imagined” improvement. Contemporary neuroscience and clinical research demonstrate something more precise and more challenging: placebo responses are real, measurable biological effects produced by the brain’s predictive and regulatory systems.

Placebos do not work because people are naïve. They work because the nervous system is designed to anticipate, regulate, and optimize physiological states based on expectation and meaning.

## **1\. Placebo Responses as Functional Adaptations**

At its core, the placebo effect reflects the brain’s ability to mobilize endogenous regulatory mechanisms—including analgesia, immune modulation, and autonomic control—when improvement is expected. From an evolutionary perspective, this makes sense. If the organism detects signals of safety, care, or effective intervention, it is adaptive to:

* reduce defensive responses,  
* lower pain and inflammation,  
* shift resources toward repair and recovery.

Expectation is not a belief layered on top of physiology; it is part of the causal chain.

## **2\. Neurobiological Mechanisms of Placebo Effects**

Neuroimaging and pharmacological studies show that placebo responses involve well-characterized neural and biochemical pathways, including:

* activation of prefrontal and anterior cingulate regions associated with meaning and control,  
* modulation of brainstem and spinal nociceptive pathways,  
* release of endogenous opioids and dopamine.

Crucially, placebo effects can be blocked by opioid antagonists, demonstrating that they are not subjective illusions but biochemically mediated processes. The brain uses prior experience, context, and expectation to generate predictions about bodily states. When those predictions signal relief, the body adjusts accordingly.

## **3\. Learning, Conditioning, and Secondary Gain**

Placebo effects are strengthened through learning and conditioning. Repeated pairings of treatments with relief train the nervous system to respond before the active agent takes effect—or even in its absence. This explains why:

* injections produce stronger placebo effects than pills,  
* larger pills outperform smaller ones,  
* sham surgeries outperform sham medications.

From a regulation standpoint, placebo responses also provide secondary benefits:

* restoration of predictability,  
* reduction of uncertainty,  
* reinforcement of trust in external or internal regulators.

As long as these regulatory gains occur, placebo mechanisms remain available and active.

## **4\. Why “It’s Just Placebo” Is Scientifically Wrong**

Dismissing placebo effects as “not real” reflects a category error. The relevant question is not whether an effect is placebo-mediated, but through which mechanisms improvement occurs.

Modern medicine routinely relies on placebo-responsive systems—often unknowingly. When these systems are ignored or pathologized, opportunities for healing are lost. When they are intentionally harnessed, outcomes improve.

The scientific task is not to eliminate placebo responses, but to understand, predict, and ethically integrate them. In that sense, Tony shifts the placebo expectation from the medication towards the learnings and methods he is presenting.

## **5\. Implications for Treatment and Change**

Placebo research demonstrates a broader principle: meaning, expectation, and context are active biological variables.

Change occurs when the nervous system receives sufficient evidence that regulation and recovery are possible. When that evidence is strong enough, endogenous systems do the work—sometimes more effectively than external interventions.

Placebos do not replace medicine. They reveal how much medicine already depends on the brain’s capacity to regulate itself.

## **References**

1. Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005). Neurobiological mechanisms of the placebo effect. Journal of Neuroscience, 25(45), 10390–10402. [https://doi.org/10.1523/JNEUROSCI.3458-05.2005](https://doi.org/10.1523/JNEUROSCI.3458-05.2005)   
2. Wager, T. D., & Atlas, L. Y. (2015). The neuroscience of placebo effects: Connecting context, learning and health. Nature Reviews Neuroscience, 16(7), 403–418. https://doi.org/10.1038/nrn3976  
3. Colloca, L., & Benedetti, F. (2005). Placebos and painkillers: Is mind as real as matter? Nature Reviews Neuroscience, 6(7), 545–552. [https://doi.org/10.1038/nrn1705](https://doi.org/10.1038/nrn1705)   
4. Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010). Biological, clinical, and ethical advances of placebo effects. The Lancet, 375(9715), 686–695. https://doi.org/10.1016/S0140-6736(09)61706-2  
5. Zubieta, J.-K., Bueller, J. A., Jackson, L. R., et al. (2005). Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. Journal of Neuroscience, 25(34), 7754–7762.  [https://doi.org/10.1523/JNEUROSCI.0439-05.2005](https://doi.org/10.1523/JNEUROSCI.0439-05.2005)   
6. Kaptchuk, T. J., & Miller, F. G. (2015). Placebo effects in medicine. New England Journal of Medicine, 373(1), 8–9. [https://doi.org/10.1056/NEJMp1504023](https://doi.org/10.1056/NEJMp1504023) 

## 

# \#3 What Xanax Is – and What It Actually Does  {##3-what-xanax-is-–-and-what-it-actually-does}

# Benzodiazepines, Acute Anxiety, and the Misattribution of Relief

Xanax (alprazolam) is a short-acting benzodiazepine widely prescribed for panic disorder and acute anxiety. Clinically, it is classified as an anxiolytic sedative, not a curative intervention. Its primary function is temporary suppression of central nervous system arousal.

## **1\. What Xanax Does Mechanistically**

Xanax (active substance: alprazolam) is a medication that turns down the volume of the nervous system. It does not solve the cause of anxiety and it does not remove fear at its root. What it does is reduce how strongly the body’s alarm system reacts.

As a result, people usually feel calmer, less tense, and less overwhelmed. That is the benefit. The trade-off is that Xanax does not only reduce fear. It also dampens alertness, emotional processing, and learning. This is why it can interfere with long-term recovery if it becomes the main strategy.

This results in:

* reduced neuronal firing,  
* decreased autonomic arousal,  
* muscle relaxation,  
* subjective calming and sedation.

Importantly, Xanax does not target the cause of anxiety or panic, but dampens the system globally. It lowers signal intensity; it does not change signal meaning.

## **2\. Onset of Action**

Tony states that Xanax cannot be what stops a panic attack in the moment because it takes too long to act. Oral alprazolam has a time to peak plasma concentration of \~1–2 hours. Subjective calming can begin earlier in some individuals (\~20–40 minutes), but this is not fast enough to abort an acute panic attack, which typically peaks within 5–10 minutes.

Therefore: If panic resolves before that window, like in this case, the termination is not pharmacological.

## **3\. Misattribution, Placebo, and Learned Dependence**

Where Xanax becomes clinically problematic is not only its pharmacology, but its attributional learning effect.

Repeated pairing of “panic → pill → relief” trains the nervous system to:

* externalize control,  
* downregulate self-regulation confidence,  
* amplify anticipatory anxiety (“What if I don’t have it?”).

This is not merely psychological. Conditioning studies show that benzodiazepines interfere with extinction learning, meaning the brain fails to learn that panic is survivable without external dampening.

Conceptualizing Xanax as a placebo for immediate control is correct, the scientifically used term would be ‘expectancy-driven misattribution layered onto delayed pharmacological sedation’.

## **4\. Dependence, Tolerance, and Long-Term Cost**

Benzodiazepines carry well-documented risks:

* tolerance (dose escalation),  
* physiological dependence,  
* rebound anxiety.

Also, the most frequently (\>10% of users) reported side effects include

* Discouragement  
* Feeling sad or empty  
* Irritability  
* Drowsiness  
* Fatigue  
* Dizziness  
* Headache

Long-term use is associated with worsened anxiety sensitivity, not improvement. This is what Tony mentions, when he says it maintains or deepens the anxiety loop, even if it reduces surface symptoms.

## **References**

1. Nutt, D. J., & Malizia, A. L. (2001). New insights into the role of the GABA\_A–benzodiazepine receptor in psychiatric disorder. British Journal of Psychiatry, 179(5), 390–396. [https://doi.org/10.1192/bjp.179.5.390](https://doi.org/10.1192/bjp.179.5.390)   
2. Baldwin, D. S., et al. (2013). Evidence-based pharmacological treatment of anxiety disorders. International Journal of Neuropsychopharmacology, 16(5), 1023–1041. [https://doi.org/10.1017/S1461145712001219](https://doi.org/10.1017/S1461145712001219)   
3. Lader, M. (2011). Benzodiazepines revisited—will we ever learn? Addiction, 106(12), 2086–2109. [https://doi.org/10.1111/j.1360-0443.2011.03563.x](https://doi.org/10.1111/j.1360-0443.2011.03563.x)   
4. Otto, M. W., et al. (2010). Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders. American Journal of Psychiatry, 167(11), 1247–1255. [https://doi.org/10.1176/appi.ajp.2010.10030412](https://doi.org/10.1176/appi.ajp.2010.10030412)   
5. Bouton, M. E. (2004). Context and behavioral processes in extinction. Learning & Memory, 11(5), 485–494. [https://doi.org/10.1101/lm.78804](https://doi.org/10.1101/lm.78804)   
6. Hofmann, S. G., et al. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36(5), 427–440. [https://doi.org/10.1007/s10608-012-9476-1](https://doi.org/10.1007/s10608-012-9476-1) 

# \#4 Why “Scrambling” Works {##4-why-“scrambling”-works}

“Scrambling” (as Tony uses it) is the deliberate disruption of a distressing phrase by repeating it and changing how it is said (cartoon voice, sexy voice, slow motion, backwards, rap, etc.). It looks silly, but it reliably targets a real problem: when words are fused with threat, they function like triggers. Scrambling aims to break that trigger function fast.

## **1\. Scrambling as an Adaptive Intervention: turning a trigger into “just sounds”**

When a phrase like “What’s wrong with me?” is repeated rapidly, it can temporarily lose its felt meaning. This effect is known as semantic satiation: repetition reduces the word’s capacity to evoke its usual meaning and emotional punch.

Tony adds a second amplifier: shifting the phrase into bizarre or playful voices. That changes the context in which the words are processed—moving them from “threat signal” to “odd stimulus.” The result is often immediate: the phrase becomes harder to take seriously.

## **2\. Neurocognitive mechanism: weakening the meaning link, not “deleting” memory**

The key claim is not “memory is erased.” The claim is: the coupling between language and emotion is loosened. Three mechanisms are most plausible and supported:

1. Semantic satiation / verbal transformation: rapid repetition reduces semantic access and changes subjective meaning (“it stops landing”). This is a well-studied phenomenon with experimental work spanning decades and continuing in current computational/neuroscience modeling.   
2. Cognitive defusion (ACT / contextual behavioral science): the goal is to reduce the believability and emotional impact of a thought by changing the context in which it is experienced. Word repetition is one of the classic defusion exercises (historically traced back to early psychology), and controlled studies show it can reduce both discomfort and believability of negative self-referential thoughts—often more than distraction or thought suppression.   
3. Affective “re-tagging” through new pairing: when Tony makes the phrase comical or absurd, he is effectively pairing the old trigger with a new emotional tone (play/absurdity) and a new bodily state (less defensive). This is consistent with principles from evaluative conditioning—changing the emotional response to a stimulus through new pairings—supported by large-scale meta-analysis evidence. 

## **3\. Why the “voices” matter: context shift beats willpower**

Changing the phrase into Mickey Mouse / Donald Duck / sexy / backwards is not decoration. It attacks the core of verbal threat:

* Prosody changes meaning and credibility. The same words, spoken differently, are processed differently.  
* Absurdity disrupts threat appraisal. Humor/play tends to reduce defensive seriousness and makes the mind less likely to treat the phrase as a literal diagnosis.  
* Contextual control: In defusion terms, the phrase stops functioning as “truth” and starts functioning as “language.” That shift alone reduces its power.

This is exactly why scrambling often works better than “positive thinking”: it doesn’t argue with the thought. It changes the thought’s operating conditions.

## **4\. What Scrambling is not and how to use it** 

Scrambling is a brief language-based intervention that reduces cognitive fusion and emotional impact of a distressing self-referential thought via semantic satiation, contextual re-framing, and new affective pairing—thereby weakening the thought’s trigger function and restoring behavioral choice. As such it is very useful, but it is not magic.

* It is not a standalone treatment for panic disorder, it is a supplement. It targets one verbal trigger loop (self-labeling, catastrophic questioning, self-diagnosis).  
* It does not necessarily change deeper fear learning unless it is embedded in broader exposure / inhibitory learning and skills training.  
* Effects can be short-lived if the person returns immediately to the same threat-rumination habits without building alternatives.

Scrambling can have lasting impact when it creates enough psychological distance for new behavior to emerge. Its strength lies not in standing alone, but in functioning as a catalytic add-on—especially when embedded within a broader intervention framework, as in Tony’s coaching. In that context, scrambling helps loosen the grip of verbal threat just enough to make space for more durable change processes, such as breathing regulation, exposure, values-based action, and the introduction of more generative questions.

## **References**

1. Masuda, A., Hayes, S. C., Sackett, C. F., & Twohig, M. P. (2004). Cognitive defusion and self-relevant negative thoughts: Examining the impact of a ninety year old technique. Behaviour Research and Therapy, 42(4), 477–485. [https://doi.org/10.1016/j.brat.2003.10.008](https://doi.org/10.1016/j.brat.2003.10.008)   
2. Ritzert, T. R., Forsyth, J. P., Berghoff, C. R., Barnes-Holmes, D., & Nicholson, E. (2010). A controlled comparison of the word repeating technique with a word association task and other coping strategies. Journal of Behavior Therapy and Experimental Psychiatry, 41(1), 45–53. [https://doi.org/10.1016/j.jbtep.2009.09.001](https://doi.org/10.1016/j.jbtep.2009.09.001)   
3. Zhang, X., Lian, J., Yu, Z., Tang, H., Liang, D., Liu, J., & Liu, J. K. (2024). Revealing the mechanisms of semantic satiation with deep learning models. Communications Biology, 7, Article 191\. [https://www.nature.com/articles/s42003-024-05821-9](https://www.nature.com/articles/s42003-024-05821-9)   
4. Hofmann, W., De Houwer, J., Perugini, M., Baeyens, F., & Crombez, G. (2010). Evaluative conditioning in humans: A meta-analysis. Psychological Bulletin, 136(3), 390–421. [https://doi.org/10.1037/a0018916](https://doi.org/10.1037/a0018916)   
5. Sinclair, A. H., & Barense, M. D. (2019). Prediction error and memory reactivation: How incomplete reminders drive reconsolidation. Trends in Neurosciences, 42(10), 727–739. [https://doi.org/10.1016/j.tins.2019.08.007](https://doi.org/10.1016/j.tins.2019.08.007) 

